Market
The R&D-to-Market gap signals an impending shift from resin supply to specialized masterbatch control
1 / 7
The portfolio is currently characterized by a massive technical expansion in core biopolymer matrices—1,124 inventions against only 42 items of commercial coverage—indicating that the market is currently viewing a "pre-commercial" snapshot of high-complexity alloys. While public messaging focuses on simple bio-based resin substitutes, the patent record shows a heavy concentration in "programmed" materials using ultra-fine mineral fillers like 5000-7000 mesh bamboo powder and chemical coupling agents like triglycidyl isocyanurate to achieve technical parity with petroleum-based plastics. This suggests that the primary value in the supply chain is migrating from base resin producers to specialized chemical processors who control these specific compatibilizers and nanohybrids.